Oncotelic Therapeutics, Inc. (OTLC) Net income 2017–2026
Oncotelic Therapeutics, Inc. (OTLC) annual net income history from SEC filings — each fiscal year as reported, with year-over-year change.
$249.3MFY2026 · since FY2017: -$13.7M → $249.3M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2026 | $249.3M | +5610.7% |
| FY2025 | -$4.5M | +42.8% |
| FY2024 | -$7.9M | -255.1% |
| FY2023 | $5.1M | +154.3% |
| FY2022 | -$9.4M | +1.2% |
| FY2021 | -$9.5M | -43.2% |
| FY2020 | -$6.6M | -831.3% |
| FY2019 | -$712,738 | +94.8% |
| FY2018 | -$13.8M | -1.2% |
| FY2017 | -$13.7M | — |
Source: SEC XBRL filings · For reference only · Not investment advice